$AMRI (Albany Molecular Research Inc.)

$AMRI {{ '2016-01-20T17:58:33+0000' | timeago}} • Announcement

Contract research and manufacturing services company $AMRI said that Dawn Von Rohr will join as SVP, Active Pharmaceutical Ingredient (API), $AMRI's largest business unit, effective Jan. 25, 2016. Ms. Von Rohr will report to George Svokos, COO, and will be responsible for setting and implementing strategic direction for the API business unit.

$MRK {{ '2017-07-21T15:21:07+0000' | timeago}} • Announcement

President Donald Trump announced that pharma giants $MRK and $PFE are collaborating with Gorilla Glass manufacturer Corning ($GLW) for manufacturing a new glass (Valor Glass), which is superior and reliable for the delivery of injectable drugs. Corning is planning to initially invest $500MM creating 1,000 jobs at 3 facilities in US.

$ABT {{ '2017-07-20T19:55:45+0000' | timeago}} • Webcast

For 3Q17, $ABT expects adjusted EPS of $0.64-0.66, with operational sales growth expected in the mid-single digits. At current exchange rates, the company expects operational sales growth to have a negative YoY impact of around 0.5%.

$ABT {{ '2017-07-20T19:45:56+0000' | timeago}} • Webcast

$ABT said that on a comparable operational basis, 3Q17 Established Pharmaceuticals sales growth is expected in the high double-digit, while in Nutrition, sales growth is expected in low single-digit. In Diagnostics, $ABT expects sales to increase mid-to-high single digits and in Medical Devices, sales is expected to increase double-digits.

$ABT {{ '2017-07-20T17:49:19+0000' | timeago}} • Announcement

$ABT raised its full year profit forecast backed by the intention of closing the Alere acquisition in 2017. The company raised its FY17 adjusted earnings from continuing operations guidance by $0.03 to a range of $2.43-2.53 per share. Reported EPS forecast was also raised from the range of $0.92-1.02 to $1.03-1.13, reflecting double-digit growth.

$ABT {{ '2017-07-20T17:36:53+0000' | timeago}} • Announcement

Declining operating earnings and rising costs and expenses hit $ABT 2Q17 earnings as much as 54%. Earnings plunged to $283MM or $0.15 from $615MM or $0.40 per share a year earlier. Sales, however, surged 24.4% on St. Jude Medical acquisition. On an adjusted basis, $ABT reported EPS above its previous guidance range at $0.62 per share.

$INCY {{ '2017-07-20T13:24:37+0000' | timeago}} • Announcement

$INCY said first patient has been treated in Phase 3 trial of itacitinib for the first-line treatment of patients with acute graft-versus-host disease (GVHD). GVHD is a condition that might occur after an allogeneic transplant, whereby the donated bone marrow or peripheral blood stem cells view the recipient’s body as foreign and attack the body.

$ABT {{ '2017-07-20T12:52:57+0000' | timeago}} • Infographic

$ABT Abbott Laboratories Earnings AlphaGraphic: Q2 2017 Highlights

$UHS {{ '2017-07-19T22:35:19+0000' | timeago}} • Announcement

$UHS BoD approved a cash dividend of $0.10 per share on Sept. 15, 2017 to shareholders of record as of Sept. 1, 2017.

$AKRX {{ '2017-07-19T21:41:28+0000' | timeago}} • Announcement

Specialty generic pharmaceutical company $AKRX said that its shareholders have voted to approve the merger for the acquisition of Akorn by Fresenius Kabi, a subsidiary of Fresenius SE & Co. KGaA. The companies expect the acquisition to close by early 2018.

$UNH {{ '2017-07-18T21:56:14+0000' | timeago}} • Webcast

In Optum segment, $UNH is focusing on three key areas for growth; strong sales pipeline of $40Bil, growing YTD sales and backlog. On MedicareAdvantage, the company expects to outperform the market in 2018 with a positive long-term outlook for the industry. $UNH also feels that the return of insurer's fee will be the single largest headwind in 2018.

$UNH {{ '2017-07-18T21:51:39+0000' | timeago}} • Webcast

Despite forgoing over $1.8Bil in revenues due to the withdrawal from the ACA individual insurance market and the health insurance tax moratorium, $UNH revenues increased nearly 9% to $40.8Bil. Health insurer also announced that the partnership with AARP will continue through at least 2025 to offer Medicare related products under AARP brand.

$UNH {{ '2017-07-18T21:48:14+0000' | timeago}} • Webcast

Health insurance giant $UNH said it served 2.5MM more people in 2Q17 vs. 2Q16, excluding the individual market. The business model of the insurer is focused on addressing the healthcare needs of consumers in areas like group Medicare Advantage, Medicaid programs in emerging markets like Brazil and established markets.

$UNH {{ '2017-07-18T21:45:28+0000' | timeago}} • Webcast

$UNH expects its stellar performance in first half to carry forward in the second half of 2017 and into 2018. On a global basis, the insurer serves 139MM people, including 126MM in the United States. UnitedHealth believes it is on target to exceed the $200Bil mark in 2017 for the first time.

$UNH {{ '2017-07-18T14:47:02+0000' | timeago}} • Announcement

$UNH's 2Q revenues increased approx. 8% crossing $50Bil. The insurer is on target to reach annual revenues of $200Bil for the first time. Total enrollment jumped 3% to 49.5MM people. Medical care ratio (MCR), a key indicator to measure financial health of insurance firms, increased 20 bps reaching 82.2%, in line with industry standards.

$UNH {{ '2017-07-18T14:46:13+0000' | timeago}} • Announcement

$UNH, the largest health insurer in US, reported stellar results in 2Q17 backed by the growth from its Optum segment. The insurance giant raised its 2017 outlook. $UNH now expects its 2017 GAAP EPS to be $9.20-9.35 and adjusted EPS to be $9.75-9.90. UnitedHealth is the first firm in its industry to report earnings every quarter.

$UNH {{ '2017-07-18T12:59:21+0000' | timeago}} • Infographic

$UNH Unitedhealth Group, Inc. Earnings AlphaGraphics: Q2 2017 highlights

$ABT {{ '2017-07-17T12:36:21+0000' | timeago}} • Announcement

$ABT is commencing a tender offer to purchase for cash all outstanding shares of Series B Convertible Perpetual Preferred Stock of Alere Inc. at a price of $402 per share of Preferred Stock. The offer will expire at 11:59 pm, NYC time, on Aug 11, 2017. There is no financing condition to the offer.

$DEPO {{ '2017-07-13T12:48:44+0000' | timeago}} • Announcement

Pharma company $DEPO is seeking to refinance its existing $375MM principal amount of privately placed secured senior notes. The notes are due in 2022. The terms of refinancing are subject to various factors, including satisfaction of customary closing conditions.

$ABT {{ '2017-07-13T12:23:21+0000' | timeago}} • Announcement

$ABT and Bigfoot Biomedical agreed to develop and commercialize diabetes management systems, integrating $ABT's FreeStyle Libre glucose sensing technology with Bigfoot's insulin delivery solutions in the United States. $ABT will provide Bigfoot with the next generation of its FreeStyle Libre glucose sensing technology.

$PFE {{ '2017-07-13T12:13:49+0000' | timeago}} • Announcement

The FDA has accepted $PFE's filing of supplemental New Drug Application (sNDA) for XELJANZ (tofacitinib citrate), an investigational oral treatment for adult patients with moderately to severely active ulcerative colitis. The FDA has provided an anticipated Prescription Drug User Fee Act action date in March 2018 for the sNDA.

Recent Transcripts

ABT (Abbott Laboratories)
Thursday, July 20 2017 - 1:00pm
UNH (UnitedHealth Group Incorporated)
Tuesday, July 18 2017 - 12:45pm
USPH (US Physical Therapy Inc.)
Thursday, June 29 2017 - 2:30pm
MDT (Medtronic plc)
Thursday, May 25 2017 - 12:00pm
PBH (Prestige Brands Holdings, Inc.)
Thursday, May 11 2017 - 12:30pm
XON (Intrexon Corporation)
Wednesday, May 10 2017 - 8:30pm
PMC (PharMerica Corporation)
Wednesday, May 10 2017 - 2:00pm
CRL (Charles River Laboratories International, Inc.)
Wednesday, May 10 2017 - 12:30pm
DEPO (DepoMed Inc.)
Tuesday, May 9 2017 - 8:30pm
AMRI (Albany Molecular Research Inc.)
Tuesday, May 9 2017 - 12:30pm
ACET (Aceto Corp.)
Friday, May 5 2017 - 1:00pm
INCY (Incyte Corporation)
Thursday, May 4 2017 - 2:00pm
PRXL (PAREXEL International Corporation)
Thursday, May 4 2017 - 2:00pm
CBM (Cambrex Corporation.)
Thursday, May 4 2017 - 12:30pm
ARWR (Arrowhead Research Corp.)
Wednesday, May 3 2017 - 5:30pm
Q (Quintiles Transnational Holdings Inc.)
Wednesday, May 3 2017 - 1:00pm
WCG (WellCare Health Plans, Inc.)
Wednesday, May 3 2017 - 12:00pm
PFE (Pfizer Inc.)
Tuesday, May 2 2017 - 2:00pm
CAH (Cardinal Health, Inc.)
Monday, May 1 2017 - 12:30pm
SNMX (Senomyx Inc.)
Thursday, April 27 2017 - 9:00pm

AlphaGraphics you may like